These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20006707)

  • 1. Non-viral nanosystems for systemic siRNA delivery.
    David S; Pitard B; Benoît JP; Passirani C
    Pharmacol Res; 2010 Aug; 62(2):100-14. PubMed ID: 20006707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugates of small targeting molecules to non-viral vectors for the mediation of siRNA.
    Zhi D; Zhao Y; Cui S; Chen H; Zhang S
    Acta Biomater; 2016 May; 36():21-41. PubMed ID: 27045350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.
    Guo J; Fisher KA; Darcy R; Cryan JF; O'Driscoll C
    Mol Biosyst; 2010 Jul; 6(7):1143-61. PubMed ID: 20431817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular assemblies in functional siRNA delivery: where do we stand?
    Aliabadi HM; Landry B; Sun C; Tang T; Uludağ H
    Biomaterials; 2012 Mar; 33(8):2546-69. PubMed ID: 22209641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers: a tool to overcome biological barriers in siRNA delivery.
    Kumari A; Kumar V; Yadav SK
    Expert Opin Biol Ther; 2011 Oct; 11(10):1327-39. PubMed ID: 21682658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.
    Akhtar S
    Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1347-62. PubMed ID: 20929276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration.
    David S; Resnier P; Guillot A; Pitard B; Benoit JP; Passirani C
    Eur J Pharm Biopharm; 2012 Jun; 81(2):448-52. PubMed ID: 22381204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of RNAi technology for targeted therapy--a track of siRNA based agents to RNAi therapeutics.
    Zhou Y; Zhang C; Liang W
    J Control Release; 2014 Nov; 193():270-81. PubMed ID: 24816071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
    Meade BR; Dowdy SF
    Discov Med; 2009 Dec; 8(43):253-6. PubMed ID: 20040280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances of siRNA delivery by nanoparticles.
    Yuan X; Naguib S; Wu Z
    Expert Opin Drug Deliv; 2011 Apr; 8(4):521-36. PubMed ID: 21413903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivering siRNA with Dendrimers: In Vivo Applications.
    Leiro V; Santos SD; Pego AP
    Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solution.
    O'Mahony AM; Godinho BM; Cryan JF; O'Driscoll CM
    J Pharm Sci; 2013 Oct; 102(10):3469-84. PubMed ID: 23893329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of non-viral vectors for siRNA delivery].
    Yang FF; Huang W; Li YF; Gao ZG
    Yao Xue Xue Bao; 2011 Dec; 46(12):1436-43. PubMed ID: 22375415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan as a carrier for targeted delivery of small interfering RNA.
    Rudzinski WE; Aminabhavi TM
    Int J Pharm; 2010 Oct; 399(1-2):1-11. PubMed ID: 20732398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing.
    Amar-Lewis E; Azagury A; Chintakunta R; Goldbart R; Traitel T; Prestwood J; Landesman-Milo D; Peer D; Kost J
    J Control Release; 2014 Jul; 185():109-20. PubMed ID: 24794893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.